An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.
Also called NCT05089435
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Sigknow Biomedical Co., Ltd.
- Registry
-
NCT05089435
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT05089435. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-03-28 (actual); primary completion 2023-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
- Condition
- Atrial Fibrillation
- Condition
- Embolic Stroke of Undetermined Source
- Intervention (Device)
- EZYPRO® ECG Recorder
- Lead sponsor
- Sigknow Biomedical Co., Ltd.
Record details
- Record id
cardio:ct-nct05089435- Content hash
9dc4f2507df5d175e1bdf21896486fcc51472c86fbcee7a6561f0c5b2bbf39d5